TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin
- 15 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 183 (2), 275-289
- https://doi.org/10.1007/s10549-020-05789-x
Abstract
Purpose TRAF4 plays an important role in the development and progression of breast cancer, but its impact on chemotherapy resistance is as yet, however, poorly understood. Methods Western blotting, immunoprecipitation, and immunofluorescence staining were used to identify and verify that TRAF4 was a novel substrate of SIAH1 and prevented SIAH1-mediated β-catenin degradation. Cell proliferation analysis and Flow cytometry analysis were utilized to detect TRAF4′s function on the growth-inhibitory effect of etoposide. Immunohistochemistry was used to detect the expression of TRAF4, SIAH1, and β-catenin. Statistical analysis was used to analyze the relationships between them with clinical parameters and curative effect of chemotherapy pathologically. Results Our results suggested that TRAF4 prevents SIAH1-mediated β-catenin degradation. TRAF4 was a novel substrate of SIAH1 and the TRAF domain of TRAF4 was critical for binding to SIAH1. TRAF4 reduced the growth-inhibitory effect of etoposide via reducing the number of S-phase cells and suppressing cell apoptosis. Concordantly, we found that breast cancer patients with a low-TRAF4 expression benefited most from chemotherapy, who had higher tumor volume reduction rate and better pathological response, while, the high-TRAF4 expression group had lower tumor volume reduction rate and poor pathological response. Conclusions TRAF4 was a novel substrate of SIAH1 and prevented SIAH1-mediated β-catenin degradation, which explains the protective effect of TRAF4 on β-catenin during cell stress and links TRAF4 to chemotherapy resistance in tumors. These findings implicated a novel pathway for the oncogenic function of TRAF4.Keywords
Funding Information
- National Natural Science Foundation of China (81803011)
This publication has 37 references indexed in Scilit:
- Structural biology study of human TNF receptor associated factor 4 TRAF domainProtein & Cell, 2013
- TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer MetastasisMolecular Cell, 2013
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- HECT and RING finger families of E3 ubiquitin ligases at a glanceJournal of Cell Science, 2012
- SIAH-1 interacts with mammalian polyhomeotic homologues HPH2 and affects its stability via the ubiquitin–proteasome pathwayBiochemical and Biophysical Research Communications, 2010
- Direct Ubiquitination of β-Catenin by Siah-1 and Regulation by the Exchange Factor TBL1Journal of Biological Chemistry, 2010
- Siah Proteins: Novel Drug Targets in the Ras and Hypoxia PathwaysCancer Research, 2009
- The E3 Ligase TRAF6 Regulates Akt Ubiquitination and ActivationScience, 2009
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasomeHuman Molecular Genetics, 2004